Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, IL

Dr. Ariel Munitz received a PhD in Pharmacology from the Hebrew University of Jerusalem, and conducted a postdoctoral training in the field of Allergy and Immunology at the Cincinnati Children’s Hospital Medical Center. He joined the Department of Clinical Microbiology and Immunology at the Sackler Medical School of the Tel-Aviv University where he is an Associate Professor.

Dr. Munitz has established a broad and internationally recognized research program aimed at understanding the roles of eosinophils in acute and chronic mucosal inflammation. Specifically, his laboratory is interested in understating the molecular mechanisms underlying the recruitment and activation of eosinophils into the lungs and gastrointestinal tract and how to translate these pathways into novel therapeutics.

Dr. Munitz received numerous awards including the prestigious Teva Research Grant Award, the American Academy of Allergy Asthma and Immunology Sepracor Research Excellence Award and the Eva & George Klein Award given by the Israel Science Foundation. Recently, in collaboration with the Meir Hospital, Dr. Munitz’s laboratory received recognition as a Center of Excellence by the World Allergy Organization. Dr. Munitz serves as a consultant to several Israeli biotech and pharma companies and his research is supported by the US-Israel Bi-national Science Foundation, the Israel Science Foundation, The Israel Cancer Research Foundation, The Israel Cancer Association, The Israel Ministry of Health, The Fritz Thyssen Foundation and the European Union.

Speaker at
21-22 February 2019, Bruges, Belgium